TFS CAPITAL LLC - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 19.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$13,000
-92.6%
19,945
-64.1%
0.00%
-92.9%
Q3 2016$175,000
+236.5%
55,622
+229.8%
0.04%
+320.0%
Q2 2016$52,000
-87.5%
16,867
-85.3%
0.01%
-83.3%
Q1 2016$415,000
+730.0%
114,610
+960.8%
0.06%
+1100.0%
Q4 2015$50,000
-91.6%
10,804
-84.3%
0.01%
-91.4%
Q2 2015$593,00068,7770.06%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 2,535,564$7,835,0004.00%
ProQuest Associates IV LLC 1,900,000$5,871,0002.39%
Abingworth LLP 437,994$1,349,0001.41%
Hilltop Park Associates LLC 75,000$232,0000.97%
Broadfin Capital, LLC 1,154,674$3,568,0000.35%
Perceptive Advisors 1,492,156$4,611,0000.32%
Rhenman & Partners Asset Management AB 300,000$927,0000.16%
Rock Springs Capital Management LP 450,000$1,391,0000.10%
WEXFORD CAPITAL LP 145,622$450,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 15,960$49,0000.02%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders